by stefan | Nov 24, 2020 | Blog
Ghent, Belgium / Rotterdam, The Netherlands / Miami, FL, USA – November 24, 2020 Allero Therapeutics BV, a Belgian-Dutch oromucosal immunotherapy company, and Abbreos Inc., a US- based IND-stage company focused on developing treatments that dampen hyperactive...
by stefan | Sep 29, 2020 | Blog
Official launch of Immagene: Dutch company developing next-generation immuno-oncology therapeutics Immagene B.V. launched this month as a private biotech company developing next-generation precision immuno-oncology (IO) treatments. The company based in...
by stefan | Oct 30, 2019 | Blog
3 October 2019 Life sciences seed capital fund Curie Capital today announced the closing of a seed investment in Allero Therapeutics, a biopharmaceutical company focused on the development of novel immunotherapies. The company has developed a proprietary platform...
by stefan | Apr 17, 2019 | Blog
ROTTERDAM, 17 April 2019 – Swanbridge Capital, an early-stage Life Sciences venture capital fund, today announced the closing of a Seed investment in Allero Therapeutics, a biopharmaceutical company focused on the discovery and development of novel immunotherapies....
by stefan | Dec 21, 2018 | Blog, Geen categorie
TILBURG, The Netherlands, 20 December 2018 – DegenRx B.V. a biopharmaceutical company developing novel therapeutic solutions to treat neurodegenerative diseases, announced today that they have secured financing for their antibody-based gene therapy program for the...
by stefan | Jul 20, 2018 | Blog
Rotterdam, July 20th, 2018 – IPaDiC, a private company that aims to develop an implantable insulin pump, announced today that it has secured funding for the first phase of development. The funding allows IPaDiC to develop and validate a prototype of the insulin pump,...
Recent Comments